2025. Lebrikizumab Improves Atopic Dermatitis and ​Quality of Life in Patients With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab: ​ Results From the ADapt Trial. SKIN The Journal of Cutaneous Medicine. 9, 1 (Jan. 2025), s512. DOI:https://doi.org/10.25251/skin.9.supp.512.